pI: 5.8996 |
Length (AA): 397 |
MW (Da): 43540 |
Paralog Number:
8
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_126734)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G17390 | S-adenosylmethionine synthase 4 |
Arabidopsis thaliana | AT1G02500 | S-adenosylmethionine synthetase 1 |
Arabidopsis thaliana | AT4G01850 | S-adenosylmethionine synthase 2 |
Arabidopsis thaliana | AT2G36880 | S-adenosylmethionine synthase 3 |
Babesia bovis | BBOV_III009750 | s-adenosylmethionine synthetase, putative |
Brugia malayi | Bm1_09230 | S-adenosylmethionine synthetase |
Candida albicans | CaO19.8272 | likely S-adenosylmethionine synthetase similar to S. cerevisiae SAM2 (YDR502C) |
Candida albicans | CaO19.657 | likely S-adenosylmethionine synthetase similar to S. cerevisiae SAM2 (YDR502C) |
Caenorhabditis elegans | CELE_C06E7.3 | Protein SAMS-4, isoform B |
Caenorhabditis elegans | CELE_C06E7.1 | Protein SAMS-3, isoform C |
Caenorhabditis elegans | CELE_T13A10.11 | Protein SAMS-5, isoform B |
Caenorhabditis elegans | CELE_C49F5.1 | Protein SAMS-1 |
Cryptosporidium hominis | Chro.70301 | methionine adenosyltransferase |
Cryptosporidium parvum | cgd7_2650 | s-adenosylmethionine synthetase (SAM) |
Dictyostelium discoideum | DDB_G0291179 | S-adenosylmethionine synthetase |
Drosophila melanogaster | Dmel_CG2674 | S-adenosylmethionine Synthetase |
Escherichia coli | b2942 | S-adenosylmethionine synthetase |
Echinococcus granulosus | EgrG_000177400 | S adenosylmethionine synthase type 1 |
Entamoeba histolytica | EHI_004920 | S-adenosylmethionine synthetase, putative |
Entamoeba histolytica | EHI_195110 | S-adenosylmethionine synthetase, putative |
Entamoeba histolytica | EHI_174250 | S-adenosylmethionine synthetase, putative |
Echinococcus multilocularis | EmuJ_000177400 | S adenosylmethionine synthase type 1 |
Giardia lamblia | GL50803_5659 | S-adenosylmethionine synthetase |
Homo sapiens | ENSG00000151224 | methionine adenosyltransferase I, alpha |
Homo sapiens | ENSG00000168906 | methionine adenosyltransferase II, alpha |
Leishmania braziliensis | LbrM.30.3550 | S-adenosylmethionine synthetase |
Leishmania donovani | LdBPK_303560.1 | S-adenosylmethionine synthetase |
Leishmania infantum | LinJ.30.3580 | S-adenosylmethionine synthetase |
Leishmania infantum | LinJ.30.3560 | S-adenosylmethionine synthetase |
Leishmania major | LmjF.30.3500 | S-adenosylmethionine synthetase |
Leishmania major | LmjF.30.3520 | S-adenosylmethionine synthetase |
Leishmania mexicana | LmxM.29.3500 | S-adenosylmethionine synthetase |
Loa Loa (eye worm) | LOAG_06217 | methionine adenosyltransferase |
Mycobacterium leprae | ML0544 | Probable S-adenosylmethionine synthase MetK (MAT) (AdoMet synthetase) (Methionine adenosyltransferase) |
Mus musculus | ENSMUSG00000053907 | methionine adenosyltransferase II, alpha |
Mus musculus | ENSMUSG00000037798 | methionine adenosyltransferase I, alpha |
Mycobacterium tuberculosis | Rv1392 | Probable S-adenosylmethionine synthetase MetK (mat) (AdoMet synthetase) (methionine adenosyltransferase) |
Mycobacterium ulcerans | MUL_1791 | S-adenosylmethionine synthetase |
Neospora caninum | NCLIV_016880 | S-adenosylmethionine synthetase (EC 2.5.1.6), related |
Oryza sativa | 4337733 | Os05g0135700 |
Oryza sativa | 4325163 | Os01g0293000 |
Plasmodium berghei | PBANKA_0823100 | S-adenosylmethionine synthetase, putative |
Plasmodium falciparum | PF3D7_0922200 | S-adenosylmethionine synthetase |
Plasmodium knowlesi | PKNH_0720200 | S-adenosylmethionine synthetase, putative |
Plasmodium vivax | PVX_099525 | S-adenosylmethionine synthetase, putative |
Plasmodium yoelii | PY06246 | S-adenosylmethionine synthetase |
Saccharomyces cerevisiae | YLR180W | methionine adenosyltransferase SAM1 |
Saccharomyces cerevisiae | YDR502C | methionine adenosyltransferase SAM2 |
Schistosoma japonicum | Sjp_0215070 | ko:K00789 S-adenosylmethionine synthetase [EC2.5.1.6], putative |
Schistosoma japonicum | Sjp_0317260 | S-adenosylmethionine synthetase isoform type-1, putative |
Schistosoma mansoni | Smp_002080 | S-adenosylmethionine synthetase |
Schmidtea mediterranea | mk4.002822.01 | S-adenosylmethionine synthase |
Schmidtea mediterranea | mk4.028997.00 | |
Schmidtea mediterranea | mk4.003057.01 | S-adenosylmethionine synthase |
Schmidtea mediterranea | mk4.021769.00 | S-adenosylmethionine synthase |
Schmidtea mediterranea | mk4.002441.01 | |
Schmidtea mediterranea | mk4.016392.02 | |
Trypanosoma brucei gambiense | Tbg972.6.4700 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.6.4670 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.6.4690 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.6.4720 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4910 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4890 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4860 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4840 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4880 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4920 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4850 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4900 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4870 | S-adenosylmethionine synthetase, putative |
Trypanosoma congolense | TcIL3000_6_4330 | S-adenosylmethionine synthetase, putative |
Trypanosoma congolense | TcIL3000_0_37490 | S-adenosylmethionine synthetase, putative |
Trypanosoma cruzi | TcCLB.510445.50 | S-adenosylmethionine synthetase, putative |
Trypanosoma cruzi | TcCLB.506945.160 | S-adenosylmethionine synthetase, putative |
Toxoplasma gondii | TGME49_240690 | S-adenosyl methionine synthetase |
Treponema pallidum | TP0794 | S-adenosylmethionine synthetase |
Theileria parva | TP04_0893 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_145700 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_317070 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_403830 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_252200 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_453040 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_243700 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_484900 | S-adenosylmethionine synthetase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0699 | S-adenosylmethionine synthetase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.4840 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.4840 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.4840 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.4840 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2942 | Escherichia coli | essential | goodall |
CELE_T13A10.11 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | sterile | wormbase |
CELE_C49F5.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C49F5.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_C06E7.3 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C06E7.3 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_240690 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Rattus norvegicus | S-adenosylmethionine synthetase alpha and beta forms | Compounds | References |
Rattus norvegicus | S-adenosylmethionine synthetase gamma form | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | S-adenosylmethionine synthetase (MAT 1 and MAT 2) | 395 aa | 62.5% | 387 aa | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
Tb927.6.4840 | purified protein | BRENDA | A protein with this EC number or name or sequence has been purified from A protein with this EC number or name or sequence has been purified from Trypanosoma brucei brucei ( 1 ) |
5 literature references were collected for this gene.